(Total Views: 98)
Posted On: 11/27/2024 6:35:09 PM
Post# of 53537

$SHPH Shuttle Pharma Expands Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma as UVA Cancer Center Doses Its First Patient
https://www.globenewswire.com/news-release/20...tient.html
https://www.globenewswire.com/news-release/20...tient.html

